## **Core Concept**
The regulation of potassium secretion in the kidneys, particularly in the late distal tubule and collecting duct, involves several factors and hormones. One key player is the renin-angiotensin-aldosterone system (RAAS), which influences electrolyte balance. Aldosterone, a mineralocorticoid hormone, promotes sodium retention and potassium excretion.

## **Why the Correct Answer is Right**
The correct answer, . **aldosterone**, actually increases potassium secretion in the collecting duct. However, the question asks for a substance that decreases potassium secretion. The action described points towards substances that can influence potassium handling in the kidneys.

## **Why Each Wrong Option is Incorrect**
- **Option A:** **Atrial Natriuretic Peptide (ANP)** increases potassium secretion indirectly by promoting sodium delivery to the collecting duct, which enhances potassium secretion. So, it's incorrect because it does not decrease potassium secretion.
- **Option B:** **Antidiuretic Hormone (ADH)**, primarily affects water reabsorption in the collecting duct but does not directly decrease potassium secretion; its main role isn't directly linked to potassium handling in a way that decreases secretion.
- **Option C:** **Beta-2 adrenergic agonists** can increase potassium entry into cells but are not primarily known for decreasing potassium secretion in the late distal tubule/collecting duct directly.
- **Option D:** **Aldosterone** actually increases potassium secretion, making it an incorrect choice for decreasing potassium secretion.

## **Clinical Pearl / High-Yield Fact**
A key clinical point is that **aldosterone antagonists** (e.g., spironolactone) can decrease potassium secretion (or more accurately, reduce potassium loss) by blocking the effects of aldosterone on the collecting duct. This is a strategy used in managing hyperkalemia.

## **Correct Answer: B. Antidiuretic Hormone (ADH).**